In addition, TP53 gene mutations in the remaining allele of del(17p) patients have been found in 80% of these cases,25 indicating that biallelic dysfunction of this gene appears to be the main mechanism driving CLL progression and relapse in this subgroup CLL patients.20, 26. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.